Description
Bromodomain Testis-specific Protein (BrdT), human recombinant is available at Gentaur for Next week delivery.
A protein driving meiotic and post-meiotic gene expression program
Biomolecule/Target: BRDT
Alternates names: BrdT, Cancer/testis antigen 9, CT9, RING3-like protein
Synonyms: Recombinant Human Bromodomain Testis-specific Protein (BrdT)
Background Information: BrdT is similar to the RING3 protein family. It possesses 2 bromodomain motifs and a PEST sequence. The bromodomain is found in proteins that regulate transcription. BrdT drives a meiotic and post-meiotic gene expression program. It also controls the genome-wide post-meiotic genome reorganization that occurs after histone hyperacetylation in elongating spermatids. It may play a role in the transcriptional regulation of spermatogenesis. It also seems to have a structural ATP-independent role in the reorganization of acetylated chromatin. BioVision’s recombinant protein includes Bromo 1 domain (22-138 aa) with N-terminal His-tag.
Reconstitution Instructions: N/A
NCBI Gene Symbol: BRDT
Gene ID: 676
NCBI Accession: Q58F21
Additional Information
Size: |
20 µg |
Country of Manufacturing Origin: |
USA |
Country of Animal Origin: |
USA |
Gene Source: |
Human |
Recombinant: |
Yes |
Source: |
E. coli |
Purity by SDS-PAGE: |
≥98% |
Assay: |
SDS-PAGE |
Purity: |
N/A |
Assay 2: |
N/A |
Endotoxin Level: |
N/A |
Activity (Specifications/test method): |
N/A |
Biological activity: |
N/A |
Results: |
N/A |
Molecular Weight: |
13.9 kDa (117aa, 22-138 +NT-His Tag) |
Storage Temperature: |
-80°C |
Shelf Life: |
12 months |
Concentration: |
N/A |
Appearance: |
Liquid |
Handling: |
Centrifuge the vial prior to opening. |